Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Estrogen therapy can help stabilize the hairline in transfeminine individuals.

A woman's masculine features were caused by a rare ovarian tumor that produced male hormones.

A woman's severe hair loss was caused by scalp psoriasis, not the initially thought condition, and treatment improved her psoriasis but couldn't restore her lost hair.

Henna mixed with PPD can cause skin reactions, scarring, and a specific type of baldness, and needs more research to understand these effects.

Women look young for their age due to larger lips, less sun damage, and genes that prevent gray hair and wrinkles.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

The superficial temporal artery flap is a reliable method for reconstructing complex facial defects with minimal complications.

QR678 treatments were more effective and comfortable for male hair loss than PRP treatments.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

The document concludes that individualized Facial Feminization Surgery plans and comprehensive care are crucial for successful outcomes.

A new tool helps better assess and treat hair loss in Chinese men.

Injectable platelet-rich fibrin improves hair growth and reduces hair loss in women.

Nanocarriers with plant extracts show promise for safe and effective hair growth treatment.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Future hair cosmetics will be safer and more effective.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

Taking oral isotretinoin with creams worked better for treating a type of hair loss than creams alone.

Bald men may have a lower risk of testicular cancer.

Scalp reduction can treat severe hair loss, but success depends on scalp flexibility and it may cause complications like pain, infection, and cosmetic issues.

The conclusion is that three signs can help diagnose hair loss after it happens, potentially avoiding more invasive tests.

Baldness is common in Korean men (60.5%), and those with a family history are 3.1 times more likely to have hairline recession.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Equilibrium dialysis can accurately measure testosterone levels when lab results are inconsistent.

Traction alopecia is more common in African women than girls, especially when traction is applied to chemically relaxed hair; avoiding such hairstyles may reduce the risk.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Ritlecitinib is a new treatment for severe hair loss in people 12 and older.

The document concludes that follicular unit transplantation offers more natural results and better graft survival than older hair transplant methods.